Hoffman: Management of the Dialysis Patient with Sickle Cell Disease Seminars in Dialysis 29 (1): 62-70,2016.
Barbieri J, Seshasai R, Shemash A, Sedrak M, Hoffman B: Thymic neuroendocrine tumor presenting with the ectopic ACTH syndrome Journal of Thoracic Oncology 8 (6): e57-8,2013.
Tan A, Hoffman B: Patient perception of risk factors associated with chronic kidney disease morbidity and mortality Ethnicity and Disease 20 : 106-108,2010.
Current Diagnosis and Treatment in Nephrology and Hypertension Chapter 51 (Section 8): 444-452,2009.
Surgery in the Patient with Kidney Disease Medical Management of the Surgical Patient 3rd edition Chapter 18 : 605-632,2008.
Chen S, Hoffman BB, Jim B, Lee JS, Kopp JB: Tubular cells from TGF-beta 1 knockout mice show decreased fibronectin and blunted hypertrophy in high glucose Kidney Intl 65 : 1191-1204,2004.
Chen S, Lee JS, Hoffman BB: Cultured tubule cells from TGF-beta 1 knockout mice exhibit impaired hypertrophy and fibronectin expression in high glucose JASN 14 : 128A,2003.
Dell M, Hoffman BB, Leonard MB, Ziyadeh FN: Increased urinary transforming growth factor beta-1 (TGF-B1) excretion in children with posterior urethral valves Urology 56 (2): 311-4,2000.
Isono M, Mogyorosi A, Han DC, Hoffman BB: Stimulation of TGF-B type II receptor gene expression in mouse mesangial cells by high glucose and in diabetic kidney Amer Journal of Physiology 278 : F830-F838,2000.
Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA: Long term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti transforming growth factor-beta antibody in db/db diabetic mice PNAS 97 (14): 8015-20,2000.
Han DC, Hoffman BB, Guo J: Therapy with antisense TGF-B1 oligodeoxynucleotides reduces kidney weight and matrix mRNA's in diabetic mice Amer Journal of Physiology 278 : F628-F634,2000.